IL17A and colitis: The downregulated expression of IL-17A and IL-6 after DIM treatment was similar to that observed in mice with autoimmune diseases such as colitis [56] and experimental autoimmune encephalomyelitis [58], in which IL-17A and IL-6 expression was also suppressed by DIM treatment.